The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 140 (2), 450-458.e1
- https://doi.org/10.1053/j.gastro.2010.10.047
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated InterferonJournal of Pediatric Gastroenterology and Nutrition, 2010
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional OutcomesJournal of Pediatric Gastroenterology and Nutrition, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateHepatology, 2008
- Efficacy and Safety of Peginterferon-α2b and Ribavirin Combination Therapy in Children With Chronic Hepatitis C InfectionThe Pediatric Infectious Disease Journal, 2008
- Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C TrialHepatology, 2007
- The burden of hepatitis C virus infection in children: Estimated direct medical costs over a 10-year periodThe Journal of Pediatrics, 2006
- Understanding social stigma in women with hepatitis CNursing Standard, 2004
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Teratogenic effects of ribavirin on hamster and rat embryosTeratology, 1978